top of page

Canary Wharf based AviadoBio entered the clinic in April with the world's first-in-human intrathalamic delivered gene therapy for a type of dementia

  • blonca9
  • Jun 14, 2024
  • 1 min read

CEO Lisa Deschamps describes this now clinical program for frontotemporal dementia, and Aviado's broader platform for using gene therapies and silencers against neurodegenerative diseases.



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

evaluate-logo-png_seeklogo-457165-2_edited.png

Evaluate is a trusted provider of forecasting and commercial intelligence to the pharmaceutical industry. With a combination of gold standard data sources and deep pharma expertise, Evaluate helps clients make the right portfolio decisions to drive growth.

Evaluate's solutions provide a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, underpinned by consensus forecasts to 2032, pipelines, deals and more. A consulting and analytics team is on always hand to help clients address unique clinical and commercial challenges.

bottom of page